The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Qlife speaks at the Healthcare IoT conference on 24 October – managing patient data a vital question for the future!
Every day, the Danish healthcare system produces a large amount of data. In the future, new data sources, such as data from patients, personal health tools and apps, will substantially increase the amount of data even more. In order for a clinic to utilize all this information, it is important that data is presented in a simple and intuitive way and that the data management model is transparent, not least in the context of GDPR. It is about creating experience of collecting and using the new types of data for targeted treatment for the benefit of patients.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants
FINANCIAL SUMMARY - THIRD QUARTER 2020
In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offer
The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes.